Navigation Links
Selecta II Glaucoma Laser System

ProductsSelecta II Glaucoma Laser System
Company Lumenis Inc.
Item Selecta II Glaucoma Laser System
Features Q-switch produces short pulses of low energy laser light. Selectively targets pigmented cells, increasing fluid outflow. Eliminates burns that scar trabecular meshwork. Economical and efficient, treatment is performed in the physician's office.
Description The Selecta II Glaucoma Laser System is a Q-switched 532 Nd Yag laser selectively targets pigmented cells and increases fluid output, lowering intraocular pressure. The Selecta II is equipped with a Q-switch that produces a 3-nanosecond high-energy beam of light, which induces the same cell replacement mechanism as traditional argon laser therapy (ALT), but without the burn. The short pulse of the laser does not allow time for heat to spread to other cells.
Info Lumenis Inc.
Customer Service: 877-lumenis
Web site: http://www.lumenis.com

Related medicine products :

1. Selecta II Glaucoma Laser System
2. Selecta Duet
3. Selecta 1064 nm Nd:YAG Base Platform
4. Selecta Duo Photocoagulator Combination Laser
5. Selecta Trio Photocoagulator and SLT Combination Laser
6. Baerveldt Glaucoma Implant
7. Baerveldt Pars Plan Glaucoma Implant
8. Ahmed Glaucoma Valve
9. Ahmed Glaucoma Valve Flexible Plate
10. Ahmed Glaucoma Valve (small size)
11. Ahmed Glaucoma Valve with Pars Plana Clip
... Single-use spray features a clear ... during shipment. No-touch application for ... burns. Fine, even mist that ... broad areas with less pooling. ...
... Triad Plus PVP-I Prep Gel is ... Prep Gel is film forming, which ... that has been known to kill ... bacteria (including antibiotic resistant), fungi, viruses, ...
... Solution is the ... povidone-iodine. It is a ... kills gram-positive and gram-negative ... organisms), as well as ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Medicine Products:
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing designer ... stand solutions representative to the Minneapolis Home and Garden Show which is being held ... is garnering national attention is the Minneapolis Convention Center. , From its broad ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came time to ... in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand opening presented ... $51 million to purchase and renovate the 185,000 square-foot office complex, which was ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy ... The technology is so cutting edge, in fact, the U.S. Food and Drug ... procedures. However, successful patient outcomes in certain clinical stem cell procedures have shown ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... certification exam and eligibility requirements effective with the April 2017 testing period. NACCM, ... , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... analytics to accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, ... This new solution helps transform the HCC Risk Adjustment process from a ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Persistence Market ... global market for intraoperative imaging, excerpts from which ... US$ 513.9 million. According to the report, the ... the grounds of increasing adoption of minimally-invasive surgeries ... diagnostic imaging for neurosurgeries. The world,s leading medical ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic ... 9.2% over the next decade to reach approximately $8.9 billion by ... forecasts for all the given segments on global as well as ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
Breaking Medicine Technology: